Stock Alert: Ovid Therapeutics Rises 6% After Partnering With Angelini Pharma
Shares of Ovid Therapeutics Inc. (OVID) are climbing more than 6% Monday morning after the company said it has entered into an agreement with an Italian family-owned drug company, Angelini Pharma S.p.A. to manufacture and commercialize Ovid's OV101.
Source: RTTNews